About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Blockbuster Drugs on Patent Cliffs Research Report 2025 | Top Pharma Giants Face 2030 Patent Cliff with Revenue Drops Up to 62%, While Eli Lilly Offsets with 165% Surge - ResearchAndMarkets.com

The "Blockbuster Drugs on Patent Cliffs" report has been added to ResearchAndMarkets.com's offering.

This report talks about the effect of patent cliffs on blockbuster drugs, focusing on the upcoming patent cliff between 2025-2030 and which companies/drugs are affected most. Also, this report shows how ready big pharma are to withstand the effects of this patent cliff, how their pipelines can offset patent cliff losses, and different mitigation strategies that can be employed. From this report, clients can understand the different implications and opportunities that both big pharma and smaller biotechs may face during a patent cliff.

A patent cliff occurs when a drug loses its patent protection, allowing biosimilars and generics to enter the market. This typically leads to a sharp drop in revenue for the originator company as market share declines. Pharmaceutical companies need to think about their business strategies to remain competitive and sustain profitability as patents expire. As a result, pharmaceutical companies will face increased pressure to innovate, diversify, and show a strong differentiated pipeline.

The next patent cliff, between 2025 and 2030, is set to be the one of the biggest since 2010 from a loss of revenue perspective, with blockbuster drugs including Merck's Keytruda, BMS's Eliquis, and Johnson & Johnson's Darzalex/Faspro all losing market exclusivity. These drugs were among the top 15 selling drugs in 2024 but are forecast to generate a fraction of those sales in 2030.

Several of the top 15 pharma companies, such as BMS, Pfizer, and Novartis, will be significantly impacted by the upcoming patent cliff, as the revenue generated by their top five drugs is set to decrease by up to 62% in 2030. Other companies have strengthened their pipelines to offset patent cliff losses, including Eli Lilly, whose revenue is set to improve by 165% in 2030.

Pharma companies can adopt various strategies to mitigate the impact of patent cliff losses, such as mergers and acquisitions (M&A), increased investment into R&D, life cycle management, and the use of patent thickets, with each approach offering potential benefits. Therefore, companies must carefully choose strategies that not only address short-term revenue loss but also support long-term growth and innovation.

Scope

  • This report examines the upcoming patent cliff set to occur between 2025-2030.
  • The analysis focuses on what companies and drugs are most affected, potential mitigation strategies that these companies can employ, and the different implications and opportunities that big pharma and biotech companies may face during a patent cliff.

Key Topics Covered:

  • Executive Summary
  • Introduction
  • Patent Cliff
  • Drugs and Companies Impacted
  • Case Studies
  • Mitigation Strategies
  • Opportunities
  • Key Takeaways
  • Appendix

For more information about this report visit https://www.researchandmarkets.com/r/bdyq5y

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.